China NMPA Approves NUZYRA® as a Category 1 Innovative Drug for the Treatment of Patients with Community-Acquired Bacterial Pneumonia (CABP) and Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy